The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis

R Pranata, H Permana, I Huang, MA Lim… - Diabetes & Metabolic …, 2020 - Elsevier
Abstract Background and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …
被引用次数：100 相关文章
[HTML] nih.gov

[HTML][HTML] The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

R Pranata, H Permana, I Huang, MA Lim… - Diabetes & Metabolic …, 2020 - ncbi.nlm.nih.gov
Background and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

R Pranata, H Permana, I Huang, MA Lim… - 2020 - expeditiorepositorio.utadeo.edu.co
Background: and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …
[PDF] researchgate.net

[PDF][PDF] The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

R Pranata, H Permana, I Huang, MA Lim… - Diabetes & Metabolic …, 2020 - researchgate.net
abstract Background: and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

R Pranata, H Permana, I Huang, MA Lim… - Diabetes & Metabolic …, 2020 - europepmc.org
Background and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

R Pranata, H Permana, I Huang, MA Lim… - Diabetes and …, 2020 - scholar.ui.ac.id
Background: and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

R Pranata, H Permana, I Huang… - Diabetes & …, 2020 - pubmed.ncbi.nlm.nih.gov
Background and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …

[引用][C] The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

R Pranata, H Permana, I Huang, MA Lim… - Diabetes & Metabolic …, 2020 - cir.nii.ac.jp
The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease
2019 (COVID-19): A systematic review and meta-analysis | CiNii Research CiNii 国立情報学 …
[PDF] researchgate.net

[PDF][PDF] The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

R Pranata, H Permana, I Huang, MA Lim… - Diabetes & Metabolic …, 2020 - researchgate.net
abstract Background: and Aims; To investigate the association between use of angiotensin-
converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of …